Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Mucopolysaccharidosis III (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
98 pages
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pituitary ACTH Hypersecretion (Cushing Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
40 pages
Rhino-Conjunctivitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Rhino-Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Rhino-Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
74 pages
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2019
US$ 3,500.00
... Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2019
104 pages
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Anemia in Chronic Kidney Disease (Renal Anemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
146 pages
Bullous Pemphigoid - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bullous Pemphigoid (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Bullous Pemphigoid and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
120 pages
DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H2 2019
US$ 3,500.00
... DNA Gyrase Subunit B (EC 5.99.1.3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2019
35 pages
Gaucher Disease - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Gaucher Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gaucher Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
95 pages
Heart Transplant Rejection - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Heart Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Heart Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
35 pages
Hyperinsulinemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Hyperinsulinemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperinsulinemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
73 pages
Merkel Cell Carcinoma - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Merkel Cell Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Merkel Cell Carcinoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
599 pages
Middle East Respiratory Syndrome (MERS) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Middle East Respiratory Syndrome (MERS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Middle East Respiratory Syndrome (MERS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
81 pages
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Neurofibromatoses Type I (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type I (Von Recklinghausen’s Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
63 pages
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Ornithine-Transcarbamylase Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ornithine-Transcarbamylase Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
45 pages
Presbyopia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Presbyopia (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Presbyopia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
49 pages
Usher Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Usher Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Usher Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
55 pages
Wilson Disease - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Wilson Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Wilson Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
59 pages
Zika Virus Infections - Pipeline Review, H2 2019
US$ 2,000.00
... . The Zika Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Zika Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
244 pages
Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2019
US$ 3,500.00
... Human Papillomavirus Protein E6 (E6) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2019
114 pages
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2019
US$ 3,500.00
... Wilms Tumor Protein (WT33 or WT1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
December 2019
80 pages
78 kda Glucose Regulated Protein - Pipeline Review, H2 2019
US$ 3,500.00
78 kda Glucose Regulated Protein - Pipeline Review, H2 2019 SUMMARY 78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Imm...
December 2019
47 pages
Alpha 2C Adrenergic Receptor - Pipeline Review, H2 2019
US$ 3,500.00
Alpha 2C Adrenergic Receptor - Pipeline Review, H2 2019 SUMMARY Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Alpha-2C adrenergic recep...
December 2019
49 pages
Alpha Galactosidase A - Pipeline Review, H2 2019
US$ 3,500.00
Alpha Galactosidase A - Pipeline Review, H2 2019 SUMMARY Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) pipe...
December 2019
84 pages
Alpha N-Acetylglucosaminidase - Pipeline Review, H2 2019
US$ 3,500.00
Alpha N-Acetylglucosaminidase - Pipeline Review, H2 2019 SUMMARY Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Alpha-N-acetylglucosaminidase is a protein a...
December 2019
52 pages
Aminopeptidase N - Pipeline Review, H2 2019
US$ 3,500.00
Aminopeptidase N - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Aminopeptidase N - Pipeline Review, H2 2019'; Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein C...
December 2019
58 pages
Aurora Kinase A - Pipeline Review, H2 2019
US$ 3,500.00
Aurora Kinase A - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Aurora Kinase A - Pipeline Review, H2 2019'; Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kina...
December 2019
85 pages
Aurora Kinase B - Pipeline Review, H2 2019
US$ 3,500.00
Aurora Kinase B - Pipeline Review, H2 2019 SUMMARY Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Ki...
December 2019
69 pages
Aurora Kinase C - Pipeline Review, H2 2019
US$ 3,500.00
Aurora Kinase C - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Aurora Kinase C - Pipeline Review, H2 2019'; Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3...
December 2019
35 pages
C-X-C Chemokine Receptor Type 1 - Pipeline Review, H2 2019
US$ 3,500.00
C-X-C Chemokine Receptor Type 1 - Pipeline Review, H2 2019 SUMMARY C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) pipeli...
December 2019
59 pages
CancerTestis Antigen 1 - Pipeline Review, H2 2019
US$ 3,500.00
CancerTestis Antigen 1 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'CancerTestis Antigen 1 - Pipeline Review, H2 2019'; Cancer/Testis Antigen 1 (Autoimmunogenic Can...
December 2019
76 pages
Carbonic Anhydrase 9 - Pipeline Review, H2 2019
US$ 3,500.00
Carbonic Anhydrase 9 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Carbonic Anhydrase 9 - Pipeline Review, H2 2019'; Carbonic Anhydrase 9 (Carbonate Dehydratase IX o...
December 2019
50 pages
Caspase 9 - Pipeline Review, H2 2019
US$ 3,500.00
Caspase 9 - Pipeline Review, H2 2019 SUMMARY Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) pipeline Target...
December 2019
70 pages
CD40 Ligand - Pipeline Review, H2 2019
US$ 3,500.00
CD40 Ligand - Pipeline Review, H2 2019 SUMMARY CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - CD40 liga...
December 2019
74 pages
Cellular Tumor Antigen p53 - Pipeline Review, H2 2019
US$ 3,500.00
Cellular Tumor Antigen p53 - Pipeline Review, H2 2019 SUMMARY Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) pipeline Target constitutes close to...
December 2019
134 pages
Connective Tissue Growth Factor - Pipeline Review, H2 2019
US$ 3,500.00
Connective Tissue Growth Factor - Pipeline Review, H2 2019 SUMMARY Connective Tissue Growth Factor (CCN Family Member 2 or Hypertrophic Chondrocyte Specific Protein 24 or Insulin Like Growth Factor...
December 2019
83 pages
Cyclin Dependent Kinase 1 - Pipeline Review, H2 2019
US$ 3,500.00
Cyclin Dependent Kinase 1 - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Cyclin Dependent Kinase 1 - Pipeline Review, H2 2019'; Cyclin Dependent Kinase 1 (p34 Protein...
December 2019
65 pages
Cyclin Dependent Kinase 4 - Pipeline Review, H2 2019
US$ 3,500.00
Cyclin Dependent Kinase 4 - Pipeline Review, H2 2019 SUMMARY Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Cyclin-dependent kinase 4 is an enzyme enc...
December 2019
173 pages
Cyclin Dependent Kinase 6 - Pipeline Review, H2 2019
US$ 3,500.00
Cyclin Dependent Kinase 6 - Pipeline Review, H2 2019 SUMMARY Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Cell divi...
December 2019
168 pages
Cyclin Dependent Kinase 7 - Pipeline Review, H2 2019
US$ 3,500.00
Cyclin Dependent Kinase 7 - Pipeline Review, H2 2019 SUMMARY Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcriptio...
December 2019
69 pages
Cyclin Dependent Kinase 9 - Pipeline Review, H2 2019
US$ 3,500.00
Cyclin Dependent Kinase 9 - Pipeline Review, H2 2019 SUMMARY Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell...
December 2019
117 pages
Endoplasmin - Pipeline Review, H2 2019
US$ 3,500.00
Endoplasmin - Pipeline Review, H2 2019 SUMMARY Endoplasmin (94 kDa Glucose Regulated Protein or Heat Shock Protein 90 kDa Beta Member 1 or Tumor Rejection Antigen 1 or gp96 Homolog or HSP90B1) pipel...
December 2019
54 pages
Estrogen Receptor - Pipeline Review, H2 2019
US$ 3,500.00
Estrogen Receptor - Pipeline Review, H2 2019 SUMMARY Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Estrogen receptor alpha (E...
December 2019
91 pages
Formaldehyde Dehydrogenase - Pipeline Review, H2 2019
US$ 3,500.00
Formaldehyde Dehydrogenase - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Formaldehyde Dehydrogenase - Pipeline Review, H2 2019'; Formaldehyde Dehydrogenase (S Nitros...
December 2019
27 pages
